Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET PULSE-AMD, Cbeyond, Halliburton, Plug Power, Prosensa, Sarepta

Mon, 21st Apr 2014 14:00

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s)

April 21 (Reuters) - U.S. stocks opened flat on Monday as investors found few reasonsto keep buying following a strong rally last week and ahead of aheavy week of corporate earnings. The Dow Jones industrialaverage was up 0.25 percent at 16,448.9, the S&P 500 was up 0.22 percent at 1,868.98 and the Nasdaq Composite was up 0.26 percent at 4,106.1.

** HALLIBURTON CO, $63.289, +3.92 pct

The world's No. 2 oilfield services company, reportedbetter-than-expected quarterly results, helped by robustdrilling activity in Russia, Saudi Arabia and Angola.

** HASBRO INC, $55.255, +1.18 pct

The toymaker reported a quarterly profit, compared with ayear-ago loss, helped by strong demand for its toys for girls.Sales of girls' toys such as My Little Pony and Nerf Rebelleincreased 21 percent to $138.7 million in the first quarterended March 30.

** SAREPTA THERAPEUTICS INC, $36.8001, +50.82 pct

** PROSENSA HOLDING NV, $5.55, +9.47 pct

Sarepta said it would start new trials to revive the chanceof approval for its experimental muscle disorder drug after theU.S. Food and Drug Administration advised the company to submitnew safety and efficacy data.

Prosensa makes drisapersen, a competing drug that failed alate-stage trial in September 2012.

** TEVA PHARMACEUTICAL INDUSTRIES LTD, $51.01,+0.31 pct

** MYLAN INC, $47.94, +2.17 pct

** MOMENTA PHARMACEUTICALS INC, $11.9984, +8.09 pct

The U.S. Supreme Court on Friday denied a request by Teva tostay a lower-court ruling in a patent case that favored thedevelopers of generic versions of the Israel-based company'stop-selling multiple sclerosis drug Copaxone.

The decision could help pave the way for generic competitorsof Teva's Copaxone drug to go on the market as soon as nextmonth.

The lower-court ruling in July 2013 was in favor of twoteams developing cheaper generic forms of Copaxone: onecomprising Novartis AG's Sandoz Inc and MomentaPharmaceuticals, and the other comprising Mylan Inc andNatco Pharma Ltd.

** CBEYOND INC, $9.79, +38.28 pct

Privately held enterprise Internet-based communicationsservices provider Birch Communications Inc said it agreed to buythe data center and networking services provider Cbeyond Inc forabout $323 million in cash to expand its optical fiber and datacenter network.

Cbeyond shareholders will get between $9.97 and $10 pershare. At $9.97 per share, the offer represents a premium of40.8 percent over the closing price of Cbeyond's stock onThursday.

** PLUG POWER, $8.03, +9.70 pct

The US fuel cell maker said on Monday Chief Executive AndyMarsh will provide update on the company's plans for its GenKeyhydrogen fuel cells, and ReliOn acquisition At 10 am ET.

** ADVANCED MICRO DEVICES INC, $4.14, +12.20 pct

The chipmaker reported better-than-expected quarterlyresults on Thursday and its second-quarter revenue forecast wasabove analysts' estimates.

At least two brokerages raised their price targets on thestock on Monday.

** CALPINE CORP, $22.28, +4.26 pct

U.S. power and energy infrastructure owner LS Power EquityAdvisors LLC said it has agreed to buy about 3,500 MW ofgeneration resources in the southeastern United States fromCalpine for $1.57 billion. The portfolio consists of sixcombined-cycle generation facilities which use natural gas asthe primary fuel source, LS Power Equity said.

Calpine mainly owns and operates natural gas-fired andgeothermal power plants in North America.

** PERFECT WORLD CO LTD, $19.335, -1.20 pct

** SHANDA GAMES LTD, $6.71, +1.36 pct

China-based online game developer Perfect World said itjoined the consortium offering to buy rival Shanda Games.Perfect World said it would buy 30.3 million class A ShandaGames shares for $100 million from Shanda InteractiveEntertainment Ltd, a shareholder in Shanda Games.

** NU SKIN ENTERPRISES INC, $87.52, +1.27 pct

The direct-selling skincare and nutritional product companyon Saturday said its Nu Skin China unit plans to immediatelyresume corporate-hosted business meetings and will beginaccepting applications for new sales people on May 1.

"China is an important marketplace for Nu Skin and we arecommitted to operating in full compliance with China's directselling regulations to promote long-term success," the companysaid in a statement.

** TREEHOUSE FOODS INC, $72.38, +0.32 pct

The food manufacturer said it will acquire Canada-basedProtenergy Natural Foods from Whitecastle Investments Ltd,Whitecap Venture Partners and others for about C$170 million.

Protenergy Natural Foods makes private-label broth, soupsand gravies.

** GENERAL MOTORS CO, $33.95, -0.09 pct

The U.S. car giant plans to invest $12 billion in China from2014 to 2017 and build more plants next year as it competes withaggressive rivals in the world's largest auto market.

** NEWMONT MINING CORP, $25.01, +6.24 pct

The talks between Barrick Gold Corp and NewmontMining over a combination that would create a gold miningbehemoth have hit a snag, but two sources close to the situationsay the companies remain keen on a deal and discussions arelikely to resume.

** PFIZER INC, $30.71, +1.52 pct

The U.S. pharmaceutical giant has approached British rivalAstraZeneca Plc to propose a 60 billion pound ($101billion) takeover, Britain's Sunday Times reported.

** APPLE INC, $527.78, +0.54 pct

** GOOGLE INC, $539.44, -0.72 pct

Apple and Google are wooing game developers to ensure thattop game titles arrive first on devices powered by theirrespective operating system, the Wall Street Journal reported,citing people familiar with the matter.

** COMCAST CORP, $49.61, +1.04 pct

** CHARTER COMMUNICATIONS INC, $121.75, +3.33 pct

Comcast is in talks with Charter Communications over sellingor spinning off roughly 3 million subscribers worthapproximately $18 billion to $20 billion as part of thedivestitures related to its $45.3 billion takeover of TimeWarner Cable, according to a source familiar with thematter.

** VIMPELCOM LTD, $9.325, +3.61 pct

Russia's Vimpelcom has resolved a long-running dispute withthe Algerian government by selling it a majority stake in thecountry's biggest telecoms operator for $2.6 billion, while itwill keep control and slash debt.

** WALT DISNEY CO, $79.49, -0.63 pct

Walt Disney Co's cable networks are expected to record highsingle-digit growth in operating income and domestic affiliaterevenue from fiscal 2014 through 2016, Chief Financial OfficerJay Rasulo told investors on Thursday.

** SPRINT CORP, $8.57, +0.59 pct

** T-MOBILE US INC, $30.44, +0.13 pct

A possible merger between Sprint and T-Mobile could promptU.S. regulators to rewrite rules they are now weighing for a2015 auction of airwaves, according to sources familiar with theproposed regulations.

** LULULEMON ATHLETICA INC, $49.854, -3.59 pct

A U.S. judge has issued final dismissals of lawsuitsaccusing Lululemon and various company officials of defraudingshareholders by concealing defects in yoga pants.

** ATHENAHEALTH, $138.736, -4.70 pct

The healthcare IT services company on Thursday reportedfirst-quarter adjusted earnings and revenue that fell below WallStreet estimates.

Three brokerages, including Oppenheimer, Deutsche Bank andB. Riley cut their price targets on the company' stock, citingweakness in its Epocrates business - a mobile medicalapplication.

** SELECT COMFORT CORP, $18.98, +6.93 pct

The specialty mattress maker on Thursday reportedfirst-quarter sales that beat analysts' estimates, helped by a 2percent rise in comparable sales.

** WEIBO CORP, $22.65, +11.91 pct

The Chinese Twitter-like messaging service company'sU.S.-listed shares were up premarket on Monday after they soared19 percent on their debut on Thursday.

** UNITEDHEALTH GROUP INC, $76.3, +0.69 pct

The largest U.S. health insurer, said it spent more than$100 million to cover a pricey new hepatitis C drug from GileadSciences Inc in its first three months on the market,an amount that was "multiple" times what it had expected.

** ABBOTT LABORATORIES, $38.81, -0.31 pct

An Abbott Laboratories spinoff urged a federal appealscourt to revisit a ruling in a case against GlaxoSmithKline Plc, but without disturbing landmark constitutionalprotections for gays and lesbians.

** KRAFT FOODS GROUP INC, $56.83, -0.14 pct

Kraft Foods is recalling about 96,000 pounds of Oscar MayerClassic Wieners because the packages may instead contain ClassicCheese Dogs made with milk, a known allergen.

** PLATINUM UNDERWRITERS HOLDINGS LTD, $62.35, +0.31pct

Brokerage Keefe Bruyette & Woods raised the reinsuranceprovider's target price to $69 from $67, after the company'searnings for the quarter ended March 31 beat analysts' estimateswith strong underwriting, investing, and capital managementperformance. The company reported earnings per share of $2.27,higher than analysts' average estimate of $1.28, according toThomson Reuters I/B/E/S. [ID: nPn5HRfMd]

** AMERICAN TOWER CORP, $82.44, -0.25 pct

Indian conglomerate Reliance Industries Ltd' telecommunications unit, which holds nationwide 4G permits, hasagreed to lease mobile phone masts from infrastructure providerAmerican Tower Corp's local arm, the companies said in astatement on Monday.

** CHINDEX INTERNATIONAL INC, $23.69, +3.27 pct

Chinese drugmaker Shanghai Fosun Pharmaceutical Group Co Ltd has raised its offer for U.S.-listed ChindexInternational Inc by 15 percent to $223.6 million aftera bidding war for the China-focused hospital chain.

** PEOPLE'S UNITED FINANCIAL INC, $14.65, +0.76 pct

Brokerage Keefe Bruyette & Woods cut the lender's targetprice to $14.50 from $15, citing low profitability until thecompany improves return on assets and efficiency ratio.

** PRIVATEBANCORP INC, $29.93, +1.15 pct

KBW raised its price target on the stock to $34 from $33after the bank reported better-than-expected first quarterresults on Thursday, helped by commercial loan growth.

** LINEAR TECHNOLOGY CORP, $46.33, -0.09 pct

The analog chipmaker said on Thursday it expects revenue togrow 2-6 percent from $348 million in the third quarter, that is$355-$369 million. Analysts on average were expecting revenue of$365 million, according to Thomson Reuters I/B/E/S.

** RADIOSHACK CORP, $1.47, +4.26 pct

The struggling U.S. electronics chain is mired in talks withits lenders over its plans to close about 1,100 stores,complicating its turnaround efforts, the Wall Street Journalreported, citing sources close to the talks.

RadioShack, which operates about 4,300 stores in the UnitedStates, said in March that the plan needed permission from itslenders, adding that its credit agreements allowed it to closeonly about 200 stores without the approval of lead lenders, theJournal said late on Wednesday. (http://r.reuters.com/vyg68v)

The company reported a wider quarterly loss and a huge dropin sales during the holiday season.

** BIOGEN IDEC INC, $294.058, +1.21 pct

Biogen is pricing its newly approved long-acting hemophiliadrug, Alprolix, to cost U.S. patients, and insurers, about thesame per year as older, less convenient therapies whose pricecan reach about $300,000 annually.

The move could pressure rivals such as Pfizer Inc tolower prices for existing hemophilia treatments, which providepatients with life-saving infusions of a blood clotting agent,according to doctors and industry analysts.

** HILLSHIRE BRANDS CO, $36.14, +0.08 pct

The maker of Jimmy Dean sausages and Ball Park hot dogs saidit has signed a definitive agreement to acquire Van's NaturalFoods from private equity firm Catterton Partners for about $165million to expand its presence in the frozen foods category.

Van's Natural Foods makes frozen waffles and breakfastsandwiches, as well as gluten-free cereals and crackers. (Compiled by Rohit T.K. in Bangalore; Editing by Joyjeet Das)

More News
25 Sep 2023 08:37

TOP NEWS: GSK's Arexvy vaccine approved for adults over 60 in Japan

(Alliance News) - GSK PLC on Monday said the Japan Ministry of Health, Labour & Welfare has approved Arexvy for adults over 60.

Read more
25 Sep 2023 07:28

GSK's RSV vaccine gets approval in Japan

(Sharecast News) - GSK announced on Monday that its vaccine, Arexvy, has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for preventing respiratory syncytial virus (RSV) disease in adults aged 60 and over.

Read more
19 Sep 2023 09:30

GSK says new HIV PrEP medication authorised by European Commission

(Alliance News) - GSK PLC on Tuesday said the European Commission has authorised ViiV Healthcare's "superior" drug Apretude to reduce the risk of sexually acquired HIV-1 infection.

Read more
18 Sep 2023 09:40

LONDON BROKER RATINGS: Jefferies likes Energean; JPMorgan raises IDS

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
18 Sep 2023 07:57

LONDON BRIEFING: Phoenix Group hails "impressive" first-half

(Alliance News) - Stocks in London are called lower on Monday, as investors focus on the week's upcoming central bank decisions.

Read more
18 Sep 2023 07:18

US FDA approves GSK treatment for myelofibrosis

(Sharecast News) - GSK announced on Monday that the US Food and Drug Administration (FDA) has granted approval for 'Ojjaara', or momelotinib, as a treatment for adults suffering from intermediate or high-risk myelofibrosis with anaemia, including cases of primary myelofibrosis or secondary myelofibrosis.

Read more
15 Sep 2023 21:52

GSK's Ojjaara approved in US for myelofibrosis patients with anaemia

(Alliance News) - GSK PLC on Friday said Ojjaara, also known as momelotinib, has been approved in the US and the "first and only" treatment indicated for myelofibrosis patients with anaemia.

Read more
11 Sep 2023 08:24

Japan accepts GSK's regulatory filing for momelotinib for blood cancer

(Alliance News) - GSK PLC on Monday reported regulatory progress for momelotinib, as Japan's Ministry of Health, Labour & Welfare accepted a review for the blood cancer-focused drug.

Read more
11 Sep 2023 07:54

LONDON BRIEFING: Restaurant Group sells Frankie & Benny's and Chiquito

(Alliance News) - Stocks in London are called higher on Monday, ahead of a busy week of interest rate decisions and economic data.

Read more
6 Sep 2023 09:32

LONDON BROKER RATINGS: Shore says 'buy' B&M; Peel Hunt likes Halfords

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
4 Sep 2023 06:00

More UK babies to need hospital treatment over delay of GSK's RSV jab

(Alliance News) - The nation's top children's doctor has warned a delay on a new vaccine to combat respiratory syncytial virus, or RSV, will mean more babies and infants will need hospital treatment this winter.

Read more
1 Sep 2023 09:11

GSK antibody accepted for Japan review, Goldman Sachs reduces stake

(Alliance News) - GSK PLC on Friday said a new drug application for its monoclonal antibody mepolizumab has been accepted for review by the Japanese government.

Read more
1 Sep 2023 07:49

LONDON BRIEFING: Stocks seen higher; UK house prices continue to fall

(Alliance News) - Stocks in London are set to open higher on Friday as markets looked ahead to a data-heavy day.

Read more
1 Sep 2023 07:12

Japan considering GSK's Nucala drug for sinusitis treatment

(Sharecast News) - Japanese regulators are reviewing a new drug application for GSK's Nucala treatment to be used for the treatment of form of adult sinusitis, the biopharma giant announced on Friday.

Read more
23 Aug 2023 12:10

LONDON MARKET MIDDAY: Stocks rise but pound slumps on sub-par UK data

(Alliance News) - Stocks in Europe were on the up heading into Wednesday afternoon, with equity markets in a confident mood on the eve of the Jackson Hole central banking event, shaking off tepid economic data which hurt the pound and euro.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.